Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,329 | $754 | $403 | $1,266 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $73 | $0 | -$0 | $0 |
| Total Curr. Assets | $7,402 | $830 | $491 | $1,324 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,402 | $830 | $491 | $1,324 |
| Liabilities | – | – | – | – |
| Payables | $0 | $255 | $559 | $588 |
| Short-Term Debt | $0 | $93 | $93 | $93 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $423 | -$0 | $0 | $0 |
| Total Curr. Liab. | $423 | $348 | $652 | $681 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$0 | $0 |
| Total NC Liab. | $0 | $0 | -$0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $423 | $348 | $652 | $681 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$38,949 | -$37,847 | -$32,777 | -$30,597 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $45,928 | $0 | $0 | $0 |
| Total Equity | $6,979 | $481 | -$161 | $643 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,402 | $830 | $491 | $1,324 |
| Net Debt | -$7,329 | -$661 | -$310 | -$1,173 |